Accept Jesus as your personal Savior! Trump 2024!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Badly oversold. Release the 13g and explode this. Any positive news will double this quickly.
Gap officiall filled here, w/ stochastics @ 1.9 (Beyond oversold).
RSI getting hot over 76
VERO book value .51 with cash on hand .79
VERO book value .51 with cash on hand .79.
2 employs
Add when no one is looking and volume is low. They are notorious to trickle it then pop it!
Glad I stopped trading this before the dilution, but wow.
Made a lot on this before the split, but yet to get back in. Keeping on watch here though
Made a lot on this before the split, but yet to get back in. Keeping on watch here though
VERO back down to the point they ran on the debt elimination news. $7 a share debt elimination with recent move. 40.78% of Shares Held by Institutions. 69 million in revenues. 3 million macro cap.
$AZTR beating expectations…enjoy… https://app.hedgeye.com/insights/59095-earnings-season-beating-the-snot-out-of-expectations?type=cartoon
AZTR 800k cash on hand from Q2 balance sheet and $10M from recent offering… after recent cash burn currently $9M cash on hand and currently trading at $4M market cap. BUY!
AZTR is a disaster! Online Surveys offer a better return!
Avoid AZTR! Online surveys are more lucrative than that mess!
Online surveys are more lucrative then this mess.
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
AZTR… I heard a guy here in the South say, “I’m so mad I could eat Ball Bearings and crap BB’s. Pretty much sums up my thoughts here, but still
AZTR should be announcing more from its dosing trial of ATR-12. Low float, dd
Should be getting an update soon. Strong buy right here with this kind of low float.
Watch AZTR. Stating to release more positive news of late and with Sabby management recently closing their short position.
Moved to AZTR Much better opportunity with Sabby management closing their short position and the company going positive FDA approvals.
Sure and thanks for asking. Sabby management closing their short position a few days ago was a first clue it’s about to go up, and now the company is actively reporting good news. Sabby is a notorious hedge fund that can obliterate a share price, but them getting out tells you they know the company is about to have a serious upside spike.
This is a great run with staf. Also, would be looking at AZTR right now. Sabby management closing their short position a few days ago was a first clue it’s about to go up, and now the company is actively reporting news. It was $12 just last month. DD
Press releases left and right. Sabby closing their short position the other day was the first clue. This will trade not
north of $3.00 soon! Load up!
Gap fill. Going back up! $1.50 open
Sabby closed 425 thousand short position in AZTR in yesterdays report.
Sabby closed 425 thousand short position in AZTR in yesterdays report.
How about AZTR? Was $12 just days ago on patent news. Under. 70 now
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads